ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

ClinicalTrials.gov ID: NCT06095102

Public ClinicalTrials.gov record NCT06095102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas

Study identification

NCT ID
NCT06095102
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
311 participants

Conditions and interventions

Interventions

  • JNJ-77242113 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2023
Primary completion
Jun 18, 2024
Completion
Feb 16, 2027
Last update posted
Mar 12, 2026

2023 – 2027

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Center for Dermatology and Plastic Surgery Scottsdale Arizona 85260
Johnson Dermatology Fort Smith Arkansas 72916
California Dermatology & Clinical Research Institute Encinitas California 92024
Forcare Clinical Research Inc Tampa Florida 33613
Hamilton Research LLC Alpharetta Georgia 30022
Arlington Dermatology Rolling Meadows Illinois 60008
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group LLC Indianapolis Indiana 46250
Indiana Clinical Trial Center Plainfield Indiana 46168
Dermatology and Advanced Aesthetics Lake Charles Louisiana 70605
Allcutis Research 1 Beverly Massachusetts 01915
Hamzavi Dermatology Fort Gratiot Michigan 48059
Minnesota Clinical Study Center New Brighton Minnesota 55112
MediSearch Clinical Trials Saint Joseph Missouri 64506
Skin Specialists Omaha Nebraska 68144
Schweiger Dermatology Group East Windsor New Jersey 08520
Optima Research Boardman Ohio 44512
Oregon Dermatology and Research Center Portland Oregon 97210
Paddington Testing Co, Inc. Philadelphia Pennsylvania 19103
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Arlington Research Center, Inc. Arlington Texas 76011
Center for Clinical Studies 1 Houston Texas 77004
Austin Institute for Clinical Research Pflugerville Texas 78660
Progressive Clinical Research San Antonio Texas 78213
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Center for Clinical Studies Webster Texas 77598
Cope Family Medicine - Ogden Clinic Bountiful Utah 84010
Frontier Derm Partners CRO, LLC Mill Creek Washington 98012

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06095102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06095102 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →